Inve US ▾
DDDDD

3D Systems (DDD) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Information Technology· Aug 4, 2026

Source: earnings call transcript

Executive summary

3D Systems Q2 FY26 — Strong Printer Sales and Strategic Market Growth

3D Systems reported strong Q2 FY26 results, driven by significant growth in printer sales and strategic market expansion, particularly in healthcare and high-growth industrial sectors. The company is undergoing a leadership transition while maintaining focus on its core markets and metal printing capabilities, aiming for continued profitable growth despite some industrial segment headwinds and gross margin pressures from product mix.

Highlights

5
  • Printer sales increased by over 45% year-over-year, led by key platforms.

  • Healthcare business delivered solid growth, up 6.8% year-over-year to $48.1 million.

  • DMP 350 metal printer sales grew approximately 90% year-over-year, and SLA 825 polymer system sales grew approximately 125% year-over-year.

  • Semiconductor and high-performance computing business grew almost 30% year-over-year.

  • Completed cost reduction initiative delivered over $60 million in annualized savings.

Concerns

4
  • Industrial business revenue was modestly lower year-over-year, down 3.7% to $46.5 million, due to older systems replacement and noncore product offering closure.

  • Non-GAAP gross margin was 36.7%, impacted by a higher mix of hardware printer sales and less favorable materials mix.

  • Adjusted EBITDA was negative $800,000, despite an improvement from the prior year period.

  • Non-GAAP EPS was negative $0.04, an improvement of $0.02 per share compared to the prior year.

Guidance & targets

CategoryTargetConfidence
Revenue
$96 million to $99 million
high materiality
High
Adjusted EBITDA
negative $3 million to negative $1 million
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Healthcare Solutions
Remained the company's largest segment, driven by strong demand for new printing systems in medtech and dental markets, including metal printers for orthopedic implants and growth in surgical planning/trauma applications.
Medtech demand: strongPersonalized Healthcare Solutions (PHS) growth: strongDental revenue: increased
$48.1 million6.8%——
Industrial
Revenue was modestly lower year-over-year, primarily reflecting revenue not carried forward after a noncore product offering closure and lower services revenue on legacy printer installed base. This was partially offset by strong double-digit growth in aerospace and defense and data center infrastructure.
Aerospace and defense: strong salesData center infrastructure: >20% YoY growthAutomotive and motorsports materials/services revenue: solid growth
$46.5 million-3.7%2.4%—

Orderbook & backlog

Industrial printer order for reusable rocket engines one of the largest in company's history Q2 FY26

Driven by demand for casting patterns used in next-generation reusable rocket engines; spans multiple quarters, with some shipments in Q2 and more ahead. Polymer-based product with consumable access to material sales.

Product announcements

ProductTypeDetails
NextDent 300 Denture Printing Systemlaunch

Deals & partnerships

Savannah River National Laboratory (SRNL) Cooperative Research and Development Agreement (CRADA) to collaborate on new materials for extreme environments of nuclear fission and fusion reactors, component design and manufacturing, and AI optimization.

This partnership will leverage the Advanced Manufacturing Collaborative (AMC), a 63,000 square foot research and innovation center operated by SRNL on the University of South Carolina Aiken campus, which opened in 2025.

Capital programs

Metal Parts Production Capacity Expansion underway

Benefit:Adding approximately 50,000 square feet of parts production capacity

Expansion in Littleton, Colorado, focusing on U.S. customers and defense work, bringing total metal printing space to over 270,000 square feet. This expansion allows leveraging rigorous quality infrastructure essential to the medical business.

Risks & headwinds

Industrial business revenue decline Q2 FY26

down 3.7% YoY

Mitigation:Ongoing refresh of installed base with new printer platforms to drive future recurring products and services revenue; focus on high-growth markets like aerospace and defense and data center infrastructure.

Less favorable materials mix impacting gross margin Q2 FY26

impacted gross margin

Mitigation:Expected continued demand for printer hardware should drive a growing base for future materials and services revenue, which typically carry higher gross margins.

Electrical component rate limitation for denture market production Current

rate limited

Mitigation:Proactively buying ahead and working to ensure the supply chain is able to support the growth in the denture market.

Weakness in consumer-facing and general manufacturing markets H1 FY26 and ongoing

impacted Industrial revenue performance in H1 FY26

Mitigation:Strategic shift to focus investments on high-growth markets (aerospace & defense, data center infrastructure) to reduce exposure to more competitive, consumer-facing markets over time.

What to watch in Q3 FY26

NextDent 300 Lab Installations

Q3 FY26 and beyond
Current Over 100 labs by year-end (expected)
Target Progress towards multiunit deployments and continued strong acceptance

Why it matters

Indicates market penetration and future recurring revenue potential for a key growth product.

Based on our current outlook, we expect to have printers installed in more than 100 of these dental labs by year-end with a growing number of multiunit deployments to follow.

Find out whether DDD delivers this. Inve re-checks your case every morning.

Q&A highlights

What is the company's outlook for the NextDent 300 denture printing system's deployment and market penetration in 2027 and beyond?

CEO Graves expressed strong satisfaction with patient and dentist receptivity, highlighting comfort of fit and dentist productivity. He noted the goal of installing printers in over 100 dental labs by year-end and expects significant revenue growth in 2027-2029, potentially making dentures a leader in the dental segment. He also mentioned being rate-limited by electrical components for production.

“Just opening up the U.S. and Europe, Jim, could potentially bring a revenue stream that's several times the revenue stream we've had for teeth straightening for the aligner product.”

asked by James Ricchiuti · answered by Jeffrey Graves

3 min read 7 chapters

Detailed narrative

Leadership Transition Underway

CEO Jeffrey Graves announced his planned transition after more than 6 years leading 3D Systems. The succession process is just beginning and could be protracted, with Graves committed to supporting a smooth transition. He highlighted that the company is now in an enviable position, having completed significant cost reduction and product portfolio refresh, making it an attractive opportunity for a new leader to drive future growth.

Strong Product Portfolio Refresh Driving Printer Sales

The company's refreshed product portfolio is proving essential for widespread adoption of 3D printing in key production environments. Printer sales increased by over 45% in Q2 FY26, led by the DMP 350 metal printing system, the new SLA 825 polymer platform, and multi-jet printing systems for dentures. Sales of DMP 350 and SLA 825 grew approximately 90% and 125% year-over-year, respectively, demonstrating strong demand for advanced systems.

Aerospace & Defense: Reusable Rocket Engines

The aerospace and defense market, particularly space applications, is a key growth driver. Additive manufacturing is integral to advanced rocket engines for reusable launch vehicles, enabling complex geometries and high-precision investment castings. The SLA 825 system is targeted at these applications, leading to one of the largest industrial printer orders in company history for casting patterns used in next-generation reusable rocket engines, with production expected to grow significantly over the next decade.

Dental Market Expansion with NextDent 300

The NextDent 300 denture printing system, launched in late 2025 (FDA clearance) and with EU MDR approval in Q2 FY26, is seeing strong acceptance. It addresses a multi-billion dollar market opportunity, with potential annual revenue exceeding $150 million in the U.S. alone. The company expects to install printers in over 100 dental labs by year-end, generating a recurring revenue stream of over $2 million annually from initial units at highly accretive gross margins, with less than 2% market penetration currently.

Data Center Infrastructure and Advanced Energy

The data center infrastructure market, including semiconductor manufacturing equipment and GPU cooling systems, grew almost 30% year-over-year, driven by metal printed parts. The company is also expanding into advanced energy applications, including nuclear fission and fusion. A new Cooperative Research and Development Agreement (CRADA) with Savannah River National Laboratory (SRNL) will focus on new materials, component design, and AI optimization for extreme environments in nuclear reactors.

Metal Printing Differentiation and Capacity Expansion

3D Systems' metal printing technology is differentiated by its ability to print highly reactive materials like titanium and nickel-based superalloys for extreme environments, building on its medical applications foundation. Metal printer sales in H1 FY26 exceeded all of FY25. To meet rising demand for finished metal parts, the company is expanding its production facilities in Leuven, Belgium, and Littleton, Colorado, adding approximately 50,000 square feet of capacity in Littleton, targeted for grand opening in the fall.

Cost Management and Operational Efficiencies

The company completed a 6-quarter cost reduction initiative, which delivered over $60 million in annualized savings by optimizing facilities, streamlining the operating model, and reducing ongoing costs. These actions significantly contributed to improved profitability metrics, with non-GAAP operating expenses decreasing 11% year-over-year in Q2 FY26, strengthening the cost structure and enabling selective investments in R&D and capital.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.